For help on how to get the results you want, see our search tips.
2374 results
-
List item
Human medicine European public assessment report (EPAR): Adcetris
Brentuximab vedotin, Lymphoma, Non-Hodgkin; Hodgkin Disease
Date of authorisation: 25/10/2012,
, Revision: 34, Authorised, Last updated: 13/03/2023
-
List item
Human medicine European public assessment report (EPAR): Adcirca (previously Tadalafil Lilly)
tadalafil, Hypertension, Pulmonary
Date of authorisation: 01/10/2008, Revision: 17, Authorised, Last updated: 22/09/2023 -
List item
Human medicine European public assessment report (EPAR): Adempas
riociguat, Hypertension, Pulmonary
Date of authorisation: 27/03/2014, Revision: 13, Authorised, Last updated: 31/08/2023 -
List item
Human medicine European public assessment report (EPAR): Adenuric
febuxostat, Gout
Date of authorisation: 21/04/2008, Revision: 23, Authorised, Last updated: 20/04/2023 -
List item
Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 10/10/2009,
, Revision: 11, Authorised, Last updated: 08/06/2022
-
List item
Human medicine European public assessment report (EPAR): Adlumiz
anamorelin hydrochloride, Cachexia; Anorexia; Carcinoma, Non-Small-Cell Lung
Date of refusal: 16/11/2017, Refused, Last updated: 30/11/2017 -
List item
Human medicine European public assessment report (EPAR): Adrovance
colecalciferol, alendronic acid (as sodium trihydrate), Osteoporosis, Postmenopausal
Date of authorisation: 04/01/2007, Revision: 25, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Adtralza
Tralokinumab, Dermatitis, Atopic
Date of authorisation: 17/06/2021,
, Revision: 4, Authorised, Last updated: 30/10/2023
-
List item
Human medicine European public assessment report (EPAR): Advagraf
tacrolimus, Graft Rejection
Date of authorisation: 23/04/2007, Revision: 26, Authorised, Last updated: 30/10/2023 -
List item
Veterinary medicine European public assessment report (EPAR): Advasure
E2 glycoprotein of classical swine fever virus, Pigs
Date of authorisation: 02/02/2001, Revision: 5, Withdrawn, Last updated: 17/03/2008 -
List item
Human medicine European public assessment report (EPAR): Advate (updated)
Octocog alfa, Hemophilia A
Date of authorisation: 02/03/2004, Revision: 32, Authorised, Last updated: 29/11/2023 -
List item
Veterinary medicine European public assessment report (EPAR): Advocate
imidacloprid, moxidectin, Dogs; Cats; Ferrets
Date of authorisation: 02/04/2003, Revision: 23, Authorised, Last updated: 08/10/2021 -
List item
Human medicine European public assessment report (EPAR): Adynovi
rurioctocog alfa pegol, Hemophilia A
Date of authorisation: 08/01/2018,, Revision: 10, Authorised, Last updated: 03/10/2023
-
List item
Human medicine European public assessment report (EPAR): Aerinaze
desloratadine, pseudophedrine sulfate, Rhinitis, Allergic, Seasonal
Date of authorisation: 30/07/2007, Revision: 22, Authorised, Last updated: 07/12/2022 -
List item
Human medicine European public assessment report (EPAR): Aerius
desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Revision: 50, Authorised, Last updated: 02/08/2023 -
List item
Human medicine European public assessment report (EPAR): Aerivio Spiromax
salmeterol xinafoate, fluticasone propionate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 15/01/2020 -
List item
Human medicine European public assessment report (EPAR): Afinitor
everolimus, Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms
Date of authorisation: 02/08/2009, Revision: 30, Authorised, Last updated: 27/06/2022 -
List item
Human medicine European public assessment report (EPAR): Aflunov
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 28/11/2010, Revision: 15, Authorised, Last updated: 03/10/2022 -
List item
Human medicine European public assessment report (EPAR): Afstyla
lonoctocog alfa, Hemophilia A
Date of authorisation: 04/01/2017, Revision: 10, Authorised, Last updated: 25/07/2022 -
List item
Veterinary medicine European public assessment report (EPAR): Aftovaxpur DOE
Maximum three of the following purified, inactivated foot-and-mouth disease virus strains: O1 Manisa ≥ 6 PD50*; O1 BFS ≥ 6 PD50*; O Taiwan 3/97 ≥ 6 PD50*; A22 Iraq ≥ 6 PD50*; A24 Cruzeiro ≥ 6 PD50*; A Turkey 14/98 ≥ 6 PD50*; Asia 1 Shamir ≥ 6 PD50*; SAT2 Saudi Arabia ≥ 6 PD50*; * PD50 – 50% protective dose in cattle as described in Ph. Eur. monograph 0063., Pigs; Cattle; Sheep
Date of authorisation: 15/07/2013,
Date of refusal: 16/05/2013, Revision: 8, Withdrawn, Last updated: 04/07/2023 -
List item
Human medicine European public assessment report (EPAR): Agenerase
amprenavir, HIV Infections
Date of authorisation: 20/10/2000, Revision: 18, Withdrawn, Last updated: 21/06/2011 -
List item
Human medicine European public assessment report (EPAR): Aimovig
erenumab, Migraine Disorders
Date of authorisation: 26/07/2018,, Revision: 11, Authorised, Last updated: 14/08/2023
-
List item
Human medicine European public assessment report (EPAR): Airexar Spiromax
salmeterol, fluticasone propionate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 02/07/2019 -
List item
Veterinary medicine European public assessment report (EPAR): Aivlosin
tylvalosin, Pheasants; Chicken; Turkeys; Pigs
Date of authorisation: 09/09/2004, Revision: 33, Authorised, Last updated: 29/03/2021 -
List item
Human medicine European public assessment report (EPAR): Ajovy (updated)
fremanezumab, Migraine Disorders
Date of authorisation: 28/03/2019,, Revision: 10, Authorised, Last updated: 20/11/2023